कंपनी का अवलोकन
eHealth, Inc. operates as a prominent player within the financial services sector, specifically functioning as an insurance broker that facilitates consumer engagement, education, and health insurance enrollment solutions across the United States. The company's operational scope is divided into two primary segments, namely Medicare and Employer and Individual, with the Medicare segment specifically focused on the sale of Medicare-related health insurance products. Currently, the enterprise holds a market capitalization of $41.02M while generating an annual revenue of $554.01M and employing a workforce of 1665 individuals. The disparity between the company's substantial annual revenue of $554.01M and its modest market capitalization of $41.02M indicates a significant valuation compression relative to its operational scale, suggesting that the market is pricing the stock based on current profitability challenges rather than revenue volume alone.
वित्तीय स्वास्थ्य
The company reported a trailing twelve-month revenue of $554.01M, yet it posted a net income of -$10.404M, revealing a cost structure where expenses significantly outpaced earnings before interest and taxes adjustments. Despite the reported net loss, the entity generated an EBITDA of $70.38M, highlighting a robust operational cash generation capability prior to financing costs and non-operational items. This distinction between the negative net income and positive EBITDA underscores the impact of interest expenses or non-recurring charges on the bottom line, while the free cash flow stands at $68.12M, which provides the company with substantial financial flexibility to fund operations or reduce leverage without immediate external financing. The margin profile is distinct, featuring a gross margin of 100.0% which suggests high-margin service delivery, contrasted by an operating margin of 38.7% and a profit margin of 7.2%. The profit margin of 7.2% is particularly notable given the net income loss, indicating that the accounting treatment of interest or taxes materially affects the final profitability metric. Regarding liquidity and leverage, the company holds $77.22M in cash against total debt of $134.35M, resulting in a debt-to-equity ratio of 13.80 which characterizes a highly leveraged balance sheet. However, the current ratio of 3.38 demonstrates strong short-term liquidity, ensuring the firm can easily meet its immediate obligations despite the long-term debt burden. Furthermore, the return on equity is calculated at 4.2% while the return on assets stands at 3.5%, metrics that reveal management's effectiveness in generating returns is currently constrained by the high debt levels and recent earnings erosion.
मूल्यांकन आकलन
The valuation metrics present a complex picture, with a trailing P/E ratio listed as N/A due to the negative net income, while the forward P/E is calculated at 1.28, implying that the market expects earnings to recover or stabilize in the future period. The price-to-book ratio is reported at 0.07, indicating that the stock is trading at a fraction of its net asset value, which suggests the market is not pricing in a premium over the book value but rather a significant discount. Additionally, the price-to-sales ratio is 0.07 and the EV/EBITDA multiple is 6.82, figures that suggest the market is valuing the company strictly on its tangible asset base and operational cash flow rather than traditional earnings multiples. In terms of price action, the 52-week high is $7.09 and the 52-week low is $1.20, placing the current trading range within a wide band that reflects recent volatility. The stock's price relative to this historical range illustrates a significant recovery from the low but remains well below the high, reflecting the market's cautious stance on the turnaround narrative. Finally, the beta value is 1.15, which means the stock exhibits price volatility that is slightly higher than the broader market, making it more sensitive to market-wide fluctuations than a beta-neutral asset.
Growth & Income
The company's revenue growth year-over-year is 3.5%, whereas the earnings growth year-over-year is -17.6%, indicating that earnings are growing significantly slower than revenue and actually declining, which implies that cost pressures or one-time charges are weighing heavily on profitability despite stable top-line expansion. Regarding income distribution, the company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm reinvests all available earnings back into the business rather than distributing cash to shareholders. Since the earnings growth rate is negative, the sustainability of any future dividend would be questionable, but the current policy reflects a focus on capital allocation for operational needs rather than income generation. The overall growth and income profile for eHealth, Inc. is characterized by steady revenue expansion offset by declining earnings and a complete absence of dividend payouts, relying entirely on operational recovery and cash flow generation to drive future shareholder value.